In a significant move responding to global concerns over the alarming link between cough syrups and child fatalities, India's drugs regulator has imposed a ban on the use of an anti-cold drug combination for children aged below four. This decisive action follows at least 141 deaths globally, raising serious questions about safety of such medications for the vulnerable age group.